Drug recall
Apheresis Platelets, Leukocytes Reduced
FDA recall event 95002 · Class II · New York Blood Center Inc
Key facts
| Event ID | 95002 |
|---|---|
| Recall numbers | B-0414-2024 |
| Recalling firm | New York Blood Center Inc |
| Product type | Biologics |
| Products | Apheresis Platelets, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Apheresis Platelets, Leukocytes Reduced, labeled as a normal platelet yield component but should have been labeled as a low yield component, were distributed. |
| Initiation date | Apr 1, 2024 |
| Report date | Aug 14, 2024 |
| Termination date | Aug 2, 2024 |
| City | Saint Paul |
| State | MN |
| Country | United States |
| FEI number | 2170665 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: